Similar articles

• Using pharmacokinetics in drug therapy. IV: Consideration in applying pharmacokinetic and pharmacodynamic estimates to antihypertensive dosage regimens.

  Schumacher GE, Wilson AL. Schumacher GE, et al. Am J Hosp Pharm. 1979 Jun;36(6):802-5. Am J Hosp Pharm. 1979. PMID: 463900
• Coadministration of glyburide and minoxidil, drugs with opposing effects on potassium channels.

  Stein CM, Brown N, Carlson MG, Campbell P, Wood AJ. Stein CM, et al. Clin Pharmacol Ther. 1997 Jun;61(6):662-8. doi: 10.1016/S0009-9236(97)90101-6. Clin Pharmacol Ther. 1997. PMID: 9209249 Clinical Trial.
• Pharmacologic properties of minoxidil: a new hypotensive agent.

  DuCharme DW, Freyburger WA, Graham BE, Carlson RG. DuCharme DW, et al. J Pharmacol Exp Ther. 1973 Mar;184(3):662-70. J Pharmacol Exp Ther. 1973. PMID: 4631469 No abstract available.
• Evaluation of minoxidil.

  Miller DD, Love DW. Miller DD, et al. Am J Hosp Pharm. 1980 Jun;37(6):808-14. Am J Hosp Pharm. 1980. PMID: 6994495 Review.
• Amlodipine; clinical relevance of a unique pharmacokinetic profile.

  Meredith PA, Elliott HL. Meredith PA, et al. J Cardiovasc Pharmacol. 1993;22 Suppl A:S6-8. J Cardiovasc Pharmacol. 1993. PMID: 7522286 Review.